Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 502 (LINC00502) is a long non-coding RNA (lncRNA), specifically classified as a long intergenic non-coding RNA (lincRNA) located on chromosome 10q23.31 (genomic coordinates: 10:91033118–91062214)[3][5]. As a member of the lincRNA family, it does not encode a protein but may play a role in the regulation of gene expression, potentially through interactions with microRNAs or chromatin-modifying complexes, as is seen for many lincRNAs[7][9]. There is currently limited or no direct evidence that LINC00502 itself is a validated therapeutic or drug target, or that it interacts with specific drugs or biomarkers. Like many lincRNAs, its function remains incompletely characterized, and its disease relevance, including a role in cancer, is suggested by its classification but has not been specifically established for LINC00502[1][3][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 502 (LINC00502).